消除世界缓慢污染:战胜多药耐药结核病的策略
Christopher Dye1, Brian G Williams, Marcos A Espinal
1Communicable Diseases, World Health Organization, CH-1211 Geneva 27, Switzerland. dyec@who.int
概括
耐多药结核病 (MDR) 仍然是一个严重的局部问题. 标准的短期化疗可以预防流行病并减少MDR发病率,得到了更好的监测和明智使用二线药物的支持.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 多药耐药结核病 (MDR-TB) 构成了全球健康的重大威胁.
- 准确评估流行病学证据对于理解和管理MDR-TB至关重要.
- 现有的数据虽然不完美,但却为当前的控制策略提供了信息.
研究的目的:
- 审查有关多药耐药结核病的流行病学证据.
- 评估制MDR-TB全球威胁的战略.
- 为MDR-TB控制提供基于证据的建议.
主要方法:
- 对多药耐药结核病的流行病学数据的系统审查.
- 评估标准短期化疗 (SCC) 的有效性.
- 分析MDR-TB治疗中二线药物的作用和可行性.
主要成果:
- 目前,MDR-TB是一个严重但局部化的问题.
- 标准的短期化疗 (SCC) 有效地预防了MDR-TB流行病.
- 最佳实践SCC可以减少流行地区的MDR-TB发病率.
结论:
- 广泛实施SCC对于有效控制结核病至关重要.
- 改善耐药性测试和监测对于管理MDR-TB至关重要.
- 在评估成本,有效性和可行性后,应谨慎地引入二线药物.
相关概念视频
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...


